# A Comparing Study Between SJ04 and Ovidrel® in Healthy Subjects

> **NCT06599528** · PHASE1 · RECRUITING · sponsor: **Suzhou Centergene Pharmaceuticals Co.,Ltd.** · enrollment: 48 (estimated)

## Conditions studied

- Assisted Reproductive Technology
- Female Infertility

## Interventions

- **DRUG:** T-R (Test-Reference drug)
- **DRUG:** R-T (Reference-Test drug)

## Key facts

- **NCT ID:** NCT06599528
- **Lead sponsor:** Suzhou Centergene Pharmaceuticals Co.,Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-12
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06599528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06599528, "A Comparing Study Between SJ04 and Ovidrel® in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06599528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*